Your browser doesn't support javascript.
loading
An evolutionary approach to the medical implications of the tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) gene.
Sazzini, M; Zuntini, R; Farjadian, S; Quinti, I; Ricci, G; Romeo, G; Ferrari, S; Calafell, F; Luiselli, D.
Afiliação
  • Sazzini M; Dipartimento di Biologia Evoluzionistica Sperimentale, Area Antropologia, Università di Bologna, Bologna, Italy.
Genes Immun ; 10(6): 566-78, 2009 Sep.
Article em En | MEDLINE | ID: mdl-19494827
ABSTRACT
Coding variants in tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) have been implicated in common variable immunodeficiency (CVID), but the functional effects of such mutations in relation to the development of the disease have not been entirely established. To examine the potential contribution of TNFRSF13B variants to CVID, we have applied an evolutionary approach by sequencing its coding region in 451 individuals belonging to 26 worldwide populations, in addition to controls, patients with CVID and selective IgA deficiency (IgAD) from Italy. The low level of geographical structure for the observed genetic diversity and the several neutrality tests performed confirm the absence of recent population-specific selective pressures, suggesting that TNFRSF13B may be involved also in innate immune functions, rather than in adaptive immunity only. A slight excess of rare derived alleles was found in patients with CVID, and thus some of these variants may contribute to the disease, implying that CVID probably fits the rare variants rather than the common disease/common variant paradigm. This also confirms the previous suggestion that TNFRSF13B defects alone do not cause CVID and that such an extremely heterogeneous immunodeficiency might be more likely related to additional, still unknown environmental and genetic factors.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunodeficiência de Variável Comum / Polimorfismo de Nucleotídeo Único / Evolução Biológica / Proteína Transmembrana Ativadora e Interagente do CAML / Mutação Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2009 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunodeficiência de Variável Comum / Polimorfismo de Nucleotídeo Único / Evolução Biológica / Proteína Transmembrana Ativadora e Interagente do CAML / Mutação Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2009 Tipo de documento: Article